A recent survey by SwedenBIO has demonstrated a major upswing in the Swedish life science industry.
A recent survey by SwedenBIO—a national non-profit association—has demonstrated a major upswing in the Swedish life science industry. The results of the survey were revealed in a March 2, 2021 press release.
The survey targeted pharmaceutical development companies with operations in Sweden and found that a vast majority (80%) of those surveyed are planning on expanding with new hires in the coming year. Additionally, when comparing with survey results from a year ago, it was revealed that there was increased confidence in projecting future growth with 62% of those surveyed expressing a more positive view of projections now.
“The positive outcome of our follow-up survey is very encouraging for the future,” said Helena Strigård, director general, SwedenBIO, in the press release. “The results also confirm our belief that involvement with other global life science hot spots opens more opportunities for collaboration and drives growth. We have, in fact had several fruitful interactions with similar organizations in regions internationally, including California. Furthermore, the fact that overall, the disturbances due to COVID have been limited and that numerous Swedish companies have re-focused their development towards COVID-related tests or treatments, underscores the strength of the industry as a whole and how creative and dedicated our life science industry experts are.”
Further information about the survey and a special investment conference being held in April 2021 can be found on SwedenBIO’s website.
Source: SwedenBIO
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.